Home » Topics » Disease categories and therapies » Immune

Immune
RSS

HHS announces intention to out-license vaccine technology

Dec. 19, 1997

LJP-394 binds to B-cells in lupus patients

Dec. 17, 1997

La Jolla evaluates Toleragan compounds for xenotransplantation

Dec. 17, 1997

SmithKline Beecham licenses rotavirus vaccine

Dec. 16, 1997

Pediatric rotavirus vaccine approval recommended

Dec. 15, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

MedImmune and SKB establish worldwide alliance for HPV vaccines

Dec. 12, 1997

EU approves ciclosporin bulk substance

Dec. 12, 1997

Epstein-Barr virus vaccine enters phase I

Dec. 8, 1997

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...